Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Ernst Schering Research Foundation Workshop|November 23, 2006
Exploratory IND: a new regulatory strategy for early clinical drug development in the United StatesN SarapaClinical Pharmacology and Therapeutics|June 22, 2007
Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studiesN Sarapa, D J Nickens, S R Raber, et al.Clinical Pharmacokinetics|May 1, 1995
Pharmacokinetic changes in patients with oedemaB Vrhovac, N Sarapa, I Bakran, et al.Cancer Chemotherapy and Pharmacology|November 2, 2013
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanomaJ F Grippo, W Zhang, D Heinzmann, et al.Clinical Pharmacology and Therapeutics|February 12, 2015
Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phaseB Darpo, C Benson, C Dota, et al.Pageof 1